
Glycolic Acid: Exfoliates rough skin and can modestly improve signs of sun damage. Hydroquinone: Treats selected hyperpigmentation, including melasma, under an appropriate treatment plan.


Choose for rough texture and dullness; start with a mild leave-on formula.
Choose for diagnosed stubborn pigment with professional guidance and a defined review point.
Can you use both?
Glycolic acid can boost hydroquinone but adds irritation. Use them at different times or as directed by your dermatologist.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.













Acts at the outer skin: Acidity helps loosen adhesion between dead cells. Promotes surface shedding: Texture changes depend on pH and the formula.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Acts on tyrosinase pathways: Hydroquinone suppresses melanin synthesis. Targets excess pigmentation: Appropriate use and monitoring matter.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Home skincare and office peels use very different glycolic acid strengths. Clinical studies include 8% leave-on cream and professional peels from 20% to 70%.
8%
20–70%
Studied leave-on cream
Studied for sun-damaged skin. Use a finished home product as labeled; this does not establish a universal ideal percentage.
Professional peeling range
Serial office peels have used these strengths for selected concerns. These are controlled procedures, not home-use targets.
Choosing a strength: Choose a home product for your concern and skin tolerance. Ask a qualified clinician whether an office peel is appropriate.
Higher strengths: High-strength peels can cause burns, scars and lasting color changes. Do not copy a study’s peel concentration or timing at home.
Formula matters: Acidity, neutralization, contact time and layers influence peel depth. Two products with the same percentage can act differently.
4% is a common clinician-directed hydroquinone strength. In the U.S., hydroquinone skin-lightening products are not legally marketed over the counter; higher compounded strengths are not routine starting points.
4%
Clinician-directed strength
Used in melasma treatment and in the approved combination TRI-LUMA. Treatment length and the complete formula require medical guidance.
Choosing a strength: Get a diagnosis and a treatment plan for the pigmented area rather than choosing solely by concentration.
Higher strengths: More is not automatically better. Irritation and blue-black discoloration called ochronosis are important risks, especially with inappropriate or prolonged use.
Formula matters: Single-ingredient creams, compounded blends and TRI-LUMA are different products. A combination containing a steroid or retinoid needs its own instructions.
Approximate windows, not promises.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
First few weeksAssess tolerance first; pigment change is usually slower.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
4–8 weeksSome studied regimens begin showing pigment improvement.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
8–12 weeksA useful review point for benefit and irritation.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.
Stinging, peeling and irritation are possible, particularly on inflamed skin.
Can irritate; prolonged inappropriate use can cause paradoxical darkening (ochronosis).
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use to lighten normal skin broadly or continue through worsening pigmentation. US nonprescription hydroquinone skin-lightening products are not legally marketed.
Very little is absorbed through the skin and it is commonly used, but this is not a decision to make from a webpage. Ask the doctor managing your pregnancy.
More of it is absorbed through the skin than with most topicals, so it is usually stopped. Azelaic acid is the common substitute. Ask the doctor managing your pregnancy.
On the skin. The finished product delivers glycolic acid in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Loosens adhesion between outer skin cells, promoting exfoliation; concentration, pH and contact time matter.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers hydroquinone in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Suppresses melanin synthesis through tyrosinase-related activity; targeted use and monitoring matter.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Choose for rough texture and dullness; start with a mild leave-on formula.
An older 22-week vehicle-controlled trial supports modest photoaging benefits from 8% cream. Results from 50% peels cannot be transferred to everyday serums.
Choose for diagnosed stubborn pigment with professional guidance and a defined review point.
The reviewed active-comparator melasma study was small with substantial attrition. Hydroquinone has broader clinical use, but this comparison does not support indefinite treatment or unsupervised high strengths.
Sources